SEC Filings

8-K
ENVISION HEALTHCARE CORP filed this Form 8-K on 11/13/2017
Entire Document
 


Slide 6

ILLUSTRATIVE OUTLOOK BASED ON Annualized Q4 2017 Guidance Q4 Midpoint Annualized 3-6% Organic Growth 4-5% Inorganic Growth Projected Operational Efficiencies expected to be achieved over the course of 2018. (1) Midpoint of Q4’17 Adj. EBITDA Guidance Illustrative Outlook